ArriVent BioPharma, Inc. SEC filings AVBP
ArriVent BioPharma, Inc. has 160 filings in SEC EDGAR's recent list, going back to Jun 23, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | May 11, 2026 | — |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| 424B5 | Prospectus supplement | Jul 1, 2025 | — |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 2, 2024 | — |
| 424B4 | Prospectus | Jan 26, 2024 | — |
| S-1MEF | Filing | Jan 25, 2024 | — |
| S-1/A | Amended registration statement | Jan 23, 2024 | — |
| S-1/A | Amended registration statement | Jan 22, 2024 | — |
| S-1 | Registration statement | Jan 5, 2024 | — |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AVBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newtown Square, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1868279
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.